Drugs / ulixacaltamide
last change Jul 2026 re-read 3 minutes ago

ulixacaltamide

Small molecule

Developed for
essential tremor
Investigated by
Praxis Precision Medicines

Trials 3

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 22 trials · 1 met primary
Phase 2 NCT05021991 Oct 2021 → Feb 2023 essential tremor Praxis Precision Medicines Completed No outcome recorded
Phase 2 NCT05021978 Mar 2020 → Mar 2022 essential tremor Praxis Precision Medicines Completed Met primary
Phase 31 trial · 1 met primary
Phase 3 NCT06087276 Nov 2023 → Oct 2025 overdue essential tremor Praxis Precision Medicines Active not recruiting Met primary

News releases announcing trial results or a regulatory action · 1

DateIssuerRelease
2026-04-14 Praxis Precision Medicines Regulatory Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor praxismedicines.com ↗

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as ulixacaltamide ClinicalTrials.gov intervention name — accepted as the source's own label NCT06087276 ↗
Known as NP-169944 ChEMBL registry synonym — accepted as the source's own label CHEMBL3934636 ↗
Known as NP-169944 HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL3934636 ↗
Known as PRAX-944 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05021978 ↗
1

NCT05021991 ↗

Known as PRAX-944 hydrochloride ChEMBL registry synonym — accepted as the source's own label CHEMBL3934636 ↗
Known as ULIXACALTAMIDE HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL3934636 ↗
Known as Z-944 ChEMBL registry synonym — accepted as the source's own label CHEMBL3934636 ↗
Known as Z-944 HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL3934636 ↗
Modality Small molecule — CHEMBL3934636 ↗
Route Oral “Once daily oral treatment” NCT05021978 ↗